Skip to main content
. 2020 Jul 12;11(9):2465–2472. doi: 10.1111/1759-7714.13557

Table 2.

Details of patients with brain metastases

Active BM (n = 24) No active BM (n = 28)
Number of BMs; n (%)
1–3 11 (46%) 9 (32%)
4–9 9 (37%) 11 (39%)
10< 4 (17%) 8 (29%)
Largest size of BMs
Median (range) 10 mm (2–42 mm) 13 mm (6–33 mm)
Local treatment; n (%)
WBRT 2 (8%) 4 (14%)
SRS 1 (4%) 21 (75%)
WBRT and SRS 0 (0%) 2 (7%)
Surgery and SRS 0 (0%) 1 (4%)
None 21 (88%) 0 (0%)
Steroid treatment for symptoms of BMs (≥10 mg of PSL); n (%)
Yes 4 (17%) 0 (0%)
No 20 (83%) 28 (100%)